<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2054">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04805931</url>
  </required_header>
  <id_info>
    <org_study_id>COVID-19 Vaccine Rollout</org_study_id>
    <nct_id>NCT04805931</nct_id>
  </id_info>
  <brief_title>VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans</brief_title>
  <acronym>VEText</acronym>
  <official_title>COVID-19 Vaccine Rollout: VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Puget Sound Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Puget Sound Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized controlled trial that will evaluate the effectiveness of&#xD;
      two different targeted outreach interventions aimed at increasing Covid-19 vaccine uptake.&#xD;
      Veterans who are eligible for COVID-19 vaccine receipt by priority status (based on&#xD;
      institutional guidelines) will be identified. Veterans must be enrolled into Veterans Health&#xD;
      Administration (VHA) care and meet age or illness institutional priority guidelines to be&#xD;
      eligible. Veterans eligible for enrollment into the trial will be randomized in a 1:1:1&#xD;
      allocation at an individual level, using permuted block randomization (with random block&#xD;
      sizes of 3 and 6) to the following interventions:&#xD;
&#xD;
        1. Control arm - receives a text message with standard messaging&#xD;
&#xD;
        2. Arm 2 - receives a text message with a message framed for scarcity&#xD;
&#xD;
        3. Arm 3 - receives a text message with a message framed for improving the social good&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVE:&#xD;
&#xD;
      To compare the effectiveness of different text message reminders sent through an interactive&#xD;
      mobile system (VEText) at increasing Covid-19 vaccine uptake among at risk Veterans.&#xD;
&#xD;
      OVERVIEW:&#xD;
&#xD;
      This is a prospective, randomized controlled trial that will evaluate the effectiveness of&#xD;
      two different targeted outreach interventions at increasing Covid-19 vaccine uptake. Veterans&#xD;
      who are eligible for Covid-19 vaccine receipt by priority status (based on institutional&#xD;
      guidelines) will be identified. Veterans must be enrolled into VHA care and meet age or&#xD;
      illness institutional priority guidelines to be eligible. Veterans eligible for enrollment&#xD;
      into the trial will be randomized in a 1:1:1 allocation at an individual level, using&#xD;
      permuted block randomization (with random block sizes of 3 and 6) to the following&#xD;
      interventions:&#xD;
&#xD;
        1. Control arm - receives a text message with standard messaging&#xD;
&#xD;
        2. Arm 2 - receives a text message with a behavioral scarcity message&#xD;
&#xD;
        3. Arm 3 - receives a text message with a behavioral social good message&#xD;
&#xD;
      Randomization will be stratified by VA center (VA Puget Sound or American Lake).&#xD;
&#xD;
      Due to operational constraints, only one type of text message can be sent per day/batch. In&#xD;
      order to account for any potential differences with the day of the week the text message is&#xD;
      received, the three arm messages will be randomized by day of the week each week. For&#xD;
      example, week 1 will have the control group message sent on Monday, the arm 2 message sent on&#xD;
      Tuesday, and the arm 3 message sent on Wednesday. Week 2 will have the arm 2 message sent on&#xD;
      Monday, the control group message sent on Tuesday, and the arm 3 message sent on Wednesday.&#xD;
      Text messages will be sent based on the randomized order generated and will continue on those&#xD;
      days of the week that the center has vaccine available.&#xD;
&#xD;
      Our primary outcome of interest is the vaccine scheduling and/or completion rate within 7&#xD;
      days of receipt of the text message. Enrollment in the trial will occur between March 15,&#xD;
      2021 and May 1, 2021.&#xD;
&#xD;
      Primary aims:&#xD;
&#xD;
      Aim 1a: Investigate differences in vaccine scheduling/completion rates among different&#xD;
      outreach strategies. Will test the hypothesis (HA1) that the proportion of Veterans either&#xD;
      scheduling a vaccine appointment for a first dose or receiving a first vaccine dose varies&#xD;
      between targeted behavioral messaging and standard messaging (arms 2 + 3 vs. control) at 7&#xD;
      days post randomization.&#xD;
&#xD;
      Aim 1b: Investigate differences in vaccine scheduling/completion rates among different&#xD;
      outreach strategies. Will test the hypothesis (HA1) that the proportion of Veterans either&#xD;
      scheduling a vaccine appointment for a first dose or receiving a first vaccine dose varies&#xD;
      between different types of behavioral messaging (arm 2 vs. arm 3) at 7 days post&#xD;
      randomization.&#xD;
&#xD;
      Secondary aims:&#xD;
&#xD;
      None&#xD;
&#xD;
      Sub-analyses:&#xD;
&#xD;
      None&#xD;
&#xD;
      STUDY POPULATION:&#xD;
&#xD;
      All Veterans who are eligible for a first dose of Covid-19 vaccine by priority status (based&#xD;
      on institutional guidelines).&#xD;
&#xD;
      STUDY TIME PERIOD The enrollment period for the study is March 15, 2021 and May 1, 2021. Data&#xD;
      collection and analysis will continue through at least 6 months post enrollment for the last&#xD;
      Veteran evaluated.&#xD;
&#xD;
      DATA SOURCES:&#xD;
&#xD;
      Table: CDWWork.SVeteran.SMVIPerson Time period: Screening/enrollment Description: Contact&#xD;
      information for kit/letter mailing and subsequent reminder calls Variable of interest: Name,&#xD;
      address, zip code, phone number, SSN.&#xD;
&#xD;
      Table: CDWWork.SVeteran.SMVIPerson Time period: Screening/enrollment Description:&#xD;
      Demographics Analytic variable(s) of interest: DOB, age, gender, marital status, DOD (if&#xD;
      applicable), service connectedness, copay.&#xD;
&#xD;
      Table: Communicator report (not CDW table) Time period: Post randomization Description:&#xD;
      Provides automated call information Analytic variable(s) of interest: Call date/time, Patient&#xD;
      response, Result from non-response.&#xD;
&#xD;
      Table: CDWWork.Appt.Appointment, CDWWork.Dim.Location Time period: Post randomization&#xD;
      Description: Scheduled vaccination appointments Analytic variable(s) of interest: Appointment&#xD;
      date/time, location.&#xD;
&#xD;
      Table: CDWWork.Immun.Immunization, CDWWork.Dim.ImmunizationName Time period: Post&#xD;
      randomization Description: Detailed vaccination receipt records Analytic variable(s) of&#xD;
      interest: Vaccine receipt date/time, location.&#xD;
&#xD;
      STATISTICAL ANALYSES AND DESCRIPTION OF MAIN TABLES Sample size analysis assuming a baseline&#xD;
      vaccination proportion of approximately 33% among Veterans aged 65 and older (estimates based&#xD;
      on vaccination data pulled 03/10/21) the estimated total sample size required to provide at&#xD;
      least 80% power to detect a 5% difference between Arms 2 + 3 and the control arm is 4311&#xD;
      total (1437 per group).&#xD;
&#xD;
      Descriptive patient-level statistics will be presented using the Pearson chi-square test for&#xD;
      dichotomous variables and the Student's t test for continuous variables. The primary&#xD;
      intention-to-treat analysis will use logistic regression to test the association between&#xD;
      randomization group and vaccine scheduling/completion 7 days post randomization, adjusting&#xD;
      for VHA center as a stratification variable. Odds ratios and predicted probabilities from&#xD;
      this model will be reported.&#xD;
&#xD;
      All descriptive and main analyses will be performed using R version 3.6.1. P-values &lt; 0.05&#xD;
      will be considered statistically significant.&#xD;
&#xD;
        1. Aim 1a Statistical Analyses Will test the hypothesis (HA1) that the proportion of&#xD;
           Veterans scheduling an appointment for the first vaccine dose or receiving a first&#xD;
           vaccine dose varies between targeted behavioral messaging and standard messaging (arms 2&#xD;
           + 3 vs. control) at 7 days post randomization.&#xD;
&#xD;
        2. Aim 1b Statistical Analyses Will test the hypothesis (HA1) that different types of&#xD;
           behavioral messaging will have differing effects on vaccine scheduling/vaccine&#xD;
           completion at 7 days post randomization (arm 2 vs. arm 3)&#xD;
&#xD;
      STUDY OUTCOMES Primary analyses: % of first-dose vaccine appointments scheduled/vaccines&#xD;
      completed at 7 days post randomization&#xD;
&#xD;
      STUDY COVARIATES&#xD;
&#xD;
      Primary analyses:&#xD;
&#xD;
      Covariate of interest: intervention group indicator&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 15, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomized controlled, parallel groups trial</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaccine appointments scheduled/completed</measure>
    <time_frame>7 days post randomization</time_frame>
    <description>% of first-dose vaccine appointments scheduled/vaccines completed</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">4311</enrollment>
  <condition>Covid19</condition>
  <condition>Vaccine Refusal</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Will receive a text message with standard messaging used to alert veterans that they are eligible for COVID-19 vaccine and offer scheduling embedded within the text message.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scarcity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive a text message with a behavioral scarcity message used to alert veterans that they are eligible for COVID-19 vaccine and offer scheduling embedded within the text message.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Social good</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive a text message with a behavioral social good message used to alert veterans that they are eligible for COVID-19 vaccine and offer scheduling embedded within the text message.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral economics</intervention_name>
    <description>Tailored behavioral economic text messaging vs. standard text messaging</description>
    <arm_group_label>Scarcity</arm_group_label>
    <arm_group_label>Social good</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Veterans must be enrolled into VHA care&#xD;
&#xD;
          -  Veterans must meet age or illness institutional priority guidelines for eligibility&#xD;
             for COVID-19 vaccine receipt&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ashok Reddy, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karin Nelson, MD, MSHS</last_name>
    <role>Study Director</role>
    <affiliation>VA Puget Sound</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Linnaea Schuttner, MD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefanie Deeds, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alaina Mori, BA</last_name>
    <phone>(206) 247-6782</phone>
    <email>alaina.mori@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefanie Deeds, MD</last_name>
    <phone>206-314-0757</phone>
    <email>Stefanie.Deeds@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linnaea Schuttner, MD</last_name>
      <phone>206-277-6126</phone>
      <email>linnaea.schuttner@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Alaina Mori, BA</last_name>
      <phone>206-247-6782</phone>
      <email>alaina.mori@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Ashok Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Geyer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefanie Deeds, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Puget Sound Health Care System</investigator_affiliation>
    <investigator_full_name>Linnaea Schuttner</investigator_full_name>
    <investigator_title>Staff Physician</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

